Loading…
Arcadia Biosciences, Inc. is projected to rise to $0.8515 by 2027, a +23% move from its current price of $0.6913. RKDA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $0.6626 | $0.6926 | $0.724 | +0.19% |
| Jul 13 | $0.6518 | $0.6939 | $0.7388 | +0.38% |
| Jul 14 | $0.6439 | $0.6952 | $0.7507 | +0.57% |
| Jul 15 | $0.6375 | $0.6966 | $0.7611 | +0.76% |
| Jul 16 | $0.632 | $0.6979 | $0.7706 | +0.95% |
| Jul 17 | $0.6273 | $0.6992 | $0.7794 | +1.14% |
| Jul 18 | $0.623 | $0.7005 | $0.7877 | +1.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.623 | $0.7005 | $0.7877 | +1.33% |
| Week 2 | $0.6014 | $0.7099 | $0.8379 | +2.68% |
| Week 3 | $0.5871 | $0.7193 | $0.8813 | +4.05% |
| Week 4 | $0.5765 | $0.7289 | $0.9215 | +5.44% |
| Week 5 | $0.5683 | $0.7386 | $0.96 | +6.85% |
| Week 6 | $0.5616 | $0.7485 | $0.9975 | +8.27% |
| Week 7 | $0.5562 | $0.7584 | $1.03 | +9.71% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Arcadia Biosciences, Inc. is a U.S.-based company that produces and markets plant-based food and beverage products. It operates within the Consumer Defensive category and develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients.
Its products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Arcadia Biosciences markets its plant-based offerings in the United States, focusing on crop improvements and food ingredients that support farm economics and consumer products.
RKDA is Arcadia Biosciences' stock, currently trading at $0.719.
It has a market cap of $1.48M and is ranked 5193. These figures position it as a small-cap micro-cap stock within the market hierarchy.
The forecasted price outlook shows a path from a neutral start in 2026 toward higher averages by 2050, with a progression through multiple years of bullish sentiment and rising average prices, culminating in a long-run average of $2.52 by 2050 with a max of $5.79.
Overall, near term price action remains constrained around a sub-$1 level, while long-term projections imply meaningful upside potential if the forecast scenario plays out.
A major floor 40.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.9% away) — a key level to hold.
The nearest ceiling, 54.8% above — a clean break opens room to run.
A major ceiling 212.5% above — clearing it would confirm fresh momentum.
Key RKDA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RKDA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6934 | Sell | $0.6919 | Sell |
| MA 10 | $0.7037 | Sell | $0.7103 | Sell |
| MA 20 | $0.7681 | Sell | $0.7618 | Sell |
| MA 50 | $0.9126 | Sell | $0.9344 | Sell |
| MA 100 | $1.24 | Sell | $1.30 | Sell |
| MA 200 | $2.23 | Sell | $1.96 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.45 | Neutral |
| Stoch RSI (14) | 63.90 | Neutral |
| CCI (20) | -62.94 | Neutral |
| Williams %R (14) | -86.14 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -5.12 | Sell |
| Bollinger %B (20,2) | 0.32 | Neutral |
| Stochastic %K (14) | 13.86 | Buy |
| TRIX (15) | -1.24 | Sell |
| Awesome (5,34) | -0.15 | Sell |
| Ultimate (7,14,28) | 45.66 | Neutral |
| Momentum (10) | 0.01 | Buy |
| Aroon Osc (25) | -32.00 | Sell |
| Hull MA (9) | 0.67 | Buy |
| ADX (14) | 27.10 | Sell |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is Bearish, with RSI(14) at 40, indicating subdued momentum.
The stock’s short-term moving averages are $0.9757 for the SMA50 and $2.34 for the SMA200, suggesting downward pressure relative to a longer-term baseline.
Support is identified at $0.671 and resistance at $1.07. The 30-day price range runs from $0.5171 to $0.9997, highlighting a tight trading band around the current price. Volatility remains high, with annualized volatility at 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.671 | $0.6913 | $1.13 | 0% | Neutral | |
| $0.6386 | $0.8515 | $1.22 | +23% | Bullish | |
| $0.6128 | $0.8576 | $1.30 | +24% | Bullish | |
| $0.6351 | $0.9262 | $1.46 | +34% | Bullish | |
| $0.4967 | $0.7515 | $1.23 | +9% | Neutral | |
| $0.4654 | $0.7286 | $1.23 | +5% | Neutral | |
| $0.5198 | $0.8404 | $1.46 | +22% | Bullish | |
| $0.5814 | $0.9693 | $1.72 | +40% | Bullish | |
| $0.6712 | $1.15 | $2.09 | +67% | Bullish | |
| $0.6342 | $1.12 | $2.08 | +62% | Bullish | |
| $0.672 | $1.36 | $2.75 | +97% | Bullish | |
| $1.08 | $2.41 | $5.48 | +248% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.671 | $0.6913 | $0.8605 | +0.00% |
| August 2026 | $0.6524 | $0.7834 | $0.9753 | +13.33% |
| September 2026 | $0.6763 | $0.8215 | $1.04 | +4.86% |
| October 2026 | $0.6562 | $0.805 | $1.03 | -2.00% |
| November 2026 | $0.6638 | $0.8213 | $1.07 | +2.02% |
| December 2026 | $0.6863 | $0.8559 | $1.13 | +4.21% |
Click any year to see its month-by-month RKDA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The RKDA price prediction for 2026 points to an average of $0.6913 (low $0.671, high $1.13) — a potential gain of 0% on today's $0.6913. A consolidation phase looks the most probable path here.
In 2027, RKDA is projected to trade between $0.6386 and $1.22, averaging $0.8515 — a potential gain of +23% from today's $0.6913. That is up +23% on the projected 2026 average. Momentum favours further upside here.
Arcadia Biosciences, Inc.'s 2028 outlook centres on $0.8576, within a $0.6128 to $1.30 range. That is up +1% on the projected 2027 average. That marks a +24% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, RKDA could reach as high as $1.46, with a base case around $0.9262 and support toward $0.6351 — roughly +34% from $0.6913. Momentum favours further upside here.
Expect RKDA to range from $0.4967 to $1.23 through 2030. The $0.7515 average target implies a +9% move from current prices. That is -19% versus the projected 2029 average. A consolidation phase looks the most probable path here.
The RKDA price prediction for 2031 points to an average of $0.7286 (low $0.4654, high $1.23) — a potential gain of +5% on today's $0.6913. Price action looks broadly range-bound.
In 2032, RKDA is projected to trade between $0.5198 and $1.46, averaging $0.8404 — a potential gain of +22% from today's $0.6913. That is up +15% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Arcadia Biosciences, Inc.'s 2033 outlook centres on $0.9693, within a $0.5814 to $1.72 range. That is up +15% on the projected 2032 average. That marks a +40% change versus current levels. Momentum favours further upside here.
By 2034, RKDA could reach as high as $2.09, with a base case around $1.15 and support toward $0.6712 — roughly +67% from $0.6913. Buyers look set to stay in control over this stretch.
Expect RKDA to range from $0.6342 to $2.08 through 2035. The $1.12 average target implies a +62% move from current prices. That is -3% versus the projected 2034 average. Momentum favours further upside here.
The RKDA price prediction for 2040 points to an average of $1.36 (low $0.672, high $2.75) — a potential gain of +97% on today's $0.6913. Buyers look set to stay in control over this stretch.
In 2050, RKDA is projected to trade between $1.08 and $5.48, averaging $2.41 — a potential gain of +248% from today's $0.6913. That is up +77% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in RKDA today (≈ 1,446.549978 RKDA) could be worth
$3,481.93
+$2,481.93 (+248%) by 2050 · US Dollar
Based on the average projected RKDA price of $2.41 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RKDAwould be worth at today's price.
$1,000 invested in RKDA on Jul 10, 2025 (≈ 207.468872 RKDA) would be worth
$143.42
-$856.58 (-85.7%) today · 0.14× · US Dollar
Based on a RKDA entry price of $4.82 vs. today's $0.6913.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.733 | $943.11 | -5.7% |
| 1 month ago | $0.903 | $765.56 | -23.4% |
| 3 months ago | $1.32 | $523.71 | -47.6% |
| 6 months ago | $2.43 | $284.49 | -71.6% |
| 1 year ago | $4.82 | $143.42 | -85.7% |
| All time (5.0y) ago | $112 | $6.17 | -99.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RKDA forecast.
Our base-case forecast reaches $1.40 around 2050.
Implied market cap at $1.40: $3.05M
The multi-year forecast shows a gradual shift in sentiment and price levels. The 2026 forecast is Neutral with min $0.671, avg $0.719, max $1.22 and ROI 0.
From 2027 to 2029 the outlook turns bullish, with 2027 avg $0.896 and ROI 24.6, 2028 avg $0.9293 and ROI 29.2, and 2029 avg $0.9887 and ROI 37.5.
In 2030 and 2031 the sentiment is Neutral again, with 2030 avg $0.7547 and ROI 5, and 2031 avg $0.761 and ROI 5.8. The forecast remains bullish from 2032 onward, with 2032 avg $0.8906, 2033 avg $1.01, 2034 avg $1.25, and 2035 avg $1.20; 2040 and 2050 continue the rise to $1.50 and $2.52 respectively, with max values up to $3.20 and $5.79.
The associated ROIs climb across these years, reaching 23.9 in 2032, 40.6 in 2033, 73.9 in 2034, 66.3 in 2035, 108.7 in 2040, and 250.2 in 2050. This trajectory reflects a long-run bullish tilt, albeit with intermittent neutral years and the inherent uncertainty of price forecasting.
Tap a question to reveal the answer.
In 2030 the forecast shows min $0.478, avg $0.7547, max $1.28, ROI 5, sentiment Neutral.
The forecast includes bullish years in 2027, 2028, 2029 with rising averages and ROIs (2027 avg $0.896, ROI 24.6; 2028 avg $0.9293, ROI 29.2; 2029 avg $0.9887, ROI 37.5). However, 2026 and 2030–2031 are Neutral, signaling mixed near-term risk.
Yes. The max prices exceed $2 in several years: 2034 max $2.38; 2035 max $2.33; 2040 max $3.20; 2050 max $5.79.
Current price is $0.719 and market cap is $1.48M. The stock is ranked 5193.
The 30-day range is from $0.5171 to $0.9997.
Arcadia Biosciences, Inc. Community Discussion
0Share your Arcadia Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.